Concepedia

Ashish Noronha

AN

12

Publications

481

Citations

12

H-Index

2017

Active since

Affiliations

Weizmann Institute of Science(Current)

Sheba Medical Center

Technion – Israel Institute of Technology

Heidelberg University

German Cancer Research Center

Ashish Noronha is an author at Weizmann Institute of Science specializing in medicine, cancer cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2017–2025

12

Publications

12

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee et al. · Cancer Discovery · 2022 · 94 citations · Full text

A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways

Donatella Romaniello, Luigi Mazzeo, Maicol Mancini et al. · Clinical Cancer Research · 2018 · 83 citations · Full text

SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors

L. E. Roth, Swati Srivastava, Moshit Lindzen et al. · Science Signaling · 2018 · 57 citations · Full text

An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation <scp>EGFR</scp> inhibitors

Maicol Mancini, Hilah Gal, Nadège Gaborit et al. · EMBO Molecular Medicine · 2017 · 56 citations · Full text

PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR

Soma Ghosh, Nishanth Belugali Nataraj, Ashish Noronha et al. · Cell Reports · 2021 · 44 citations · Full text

, , +10

Rows per page

1–5 of 12